Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. te Brake
A Double-Blinded Randomised Placebo-Controlled Phase II Trial to Evaluate High Dose Rifampicin for Tuberculous Meningitis: A Dose Finding Study
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
High Dose Oral Rifampicin to Improve Survival From Adult Tuberculous Meningitis: A Randomised Placebo-Controlled Double-Blinded Phase III Trial (The HARVEST Study)
Wellcome Open Research
Biochemistry
Medicine
Genetics
Molecular Biology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
Orally Active Prostacyclin Analogue Beraprost Sodium in Patients With Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Dose Finding Trial
BMC Nephrology
Nephrology
Corrigendum: Perioperative Bromelain Therapy After Wisdom Teeth Extraction - A Randomized, Placebo-Controlled, Double-Blinded, Three-Armed, Cross-Over Dose-Finding Study
Phytotherapy Research
Pharmacology
A Phase II Randomized Controlled Trial Adding Oral Flucytosine to High-Dose Fluconazole, With Short-Course Amphotericin B, for Cryptococcal Meningitis
AIDS
Infectious Diseases
Allergy
Immunology
High-Dose Vitamin D3 During Intensive-Phase Antimicrobial Treatment of Pulmonary Tuberculosis: A Double-Blind Randomised Controlled Trial
The Lancet
Medicine
A Pragmatic, Phase III, Multisite, Double-Blind, Placebo-Controlled, Parallel-Arm, Dose Increment Randomised Trial of Regular, Low-Dose Extended-Release Morphine for Chronic Breathlessness: Breathlessness, Exertion and Morphine Sulfate (BEAMS) Study Protocol
BMJ Open
Medicine
Bumetanide in Hypokalaemic Periodic Paralysis: A Randomised, Double-Blind, Placebo Controlled Phase II Clinical Trial With a Crossover Design
Neuromuscular Disorders
Child Health
Neurology
Pediatrics
Perinatology
Genetics
Medium-Dose Riboflavin as a Prophylactic Agent in Children With Migraine: A Preliminary Placebo-Controlled, Randomised, Double-Blind, Cross-Over Trial
Cephalalgia
Medicine
Neurology
